Related Experiment Videos
Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in
C G Prates1, A F Martins, S V Superti
1Medical Sciences Postgraduate Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Abstract:
This study assessed risk factors for 30-day mortality in 66 patients with carbapenem-resistant Acinetobacter baumannii (CRAB) infection or colonization during an outbreak in an intensive-care unit. Clinical and demographic characteristics were evaluated. The overall 30-day mortality was 47·0%. In the multivariate Cox regression model, septic shock [adjusted hazard ratio (aHR) 5·01, 95% confidence interval (CI) 2·32-10·01] and APACHE II score at onset of infection (aHR 1·11, 95% CI 1·04-1·18) were significantly associated with 30-day mortality. Administration of appropriate therapy was a protective factor, but it was not statistically significant (aHR 0·48, 95% CI 0·21-1·12). A sample of isolates tested (n=27) carried the blaOXA-23 gene. Severity of baseline condition and severity of infection presentation were major risk factors for mortality during the outbreak. Patients who received appropriate therapy tended to have lower mortality rates, although therapy was started late and dosage was suboptimal in most cases.
Insights
This study identified key risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii (CRAB) infections. Septic shock and high APACHE II scores significantly increased mortality risk during the ICU outbreak.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant threat in intensive care units (ICUs).
- Outbreaks of CRAB necessitate understanding mortality risk factors for effective management.
Purpose of the Study:
- To identify independent risk factors associated with 30-day mortality in patients with CRAB infection or colonization.
- To evaluate the impact of clinical characteristics and treatment on mortality during a CRAB outbreak.
Main Methods:
- Retrospective analysis of 66 patients with CRAB infection or colonization during an ICU outbreak.
- Multivariate Cox regression analysis to determine predictors of 30-day mortality.
- Assessment of clinical and demographic data, including APACHE II scores and therapeutic interventions.
Main Results:
- The overall 30-day mortality rate was 47.0%.
- Septic shock (aHR 5.01) and higher APACHE II scores (aHR 1.11) were significantly associated with increased 30-day mortality.
- Appropriate therapy showed a trend towards reduced mortality (aHR 0.48) but was not statistically significant, often initiated late with suboptimal dosing.
Conclusions:
- Severe baseline condition and presentation severity are major mortality risk factors in CRAB outbreaks.
- Prompt and optimal therapeutic interventions are crucial for improving outcomes in CRAB infections.
- The blaOXA-23 gene was prevalent among tested CRAB isolates, indicating a common resistance mechanism.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Acute Respiratory Failure-III